• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Archiv fur Psychiatrie und Nervenkrankheiten

    Archiv fur Psychiatrie und Nervenkrankheiten

    JournalISSN 0940-1334eISSN 1433-8491中科院 医学 2区

    年发文量

    研究主题

    论文(9097)

    排序
    1Depressive Symptom Dimensions, Physical Activity, and Incident Dementia: a Longitudinal Analysis of Three International Cohorts
    Minghui Wang,Jielun Huang, Xueqing Zhang,Shaohui Jia,Ning Chen

    Depressive symptoms are increasingly recognized as a potentially modifiable risk factor for dementia. However, most studies have relied on total scores, thereby overlooking heterogeneity across symptom dimensions. We examined dimension-specific associations with incident dementia and the role of physical activity among 27,417 participants from the China Health and Retirement Longitudinal Study (CHARLS), the English Longitudinal Study of Ageing (ELSA), and the Health and Retirement Study (HRS). Items from the Center for Epidemiologic Studies Depression Scale (CES-D) were grouped into somatic symptoms, depressed affect, and positive affect. Incident dementia was algorithmically defined by concurrent education-stratified memory impairment and functional dependence. Cohort-specific associations were estimated using multivariable logistic regression with adjustment for baseline memory performance and pooled using random-effects meta-analysis. Higher scores for somatic symptoms and depressed affect were associated with incident dementia, with pooled odds ratios of 1.43 (95

    2026
    引用
    AI阅读
    加入学术空间
    2Towards Normalization of Cognitive Function and Psychiatric Morbidity in Patients with Neurological Symptoms Post COVID-19: a Longitudinal Study
    Siv Elin Pignatiello,Marion Boldingh, Astrid Gjerdrum Hornslien, Ingvil Okkenhaug, Arne Gramstad,Fridtjof Lund-Johansen, Mari Thoresen Løkholm,Are Hugo Pripp, Ann Christin Rivenes,Vera Solianik, Bente Alexandra Sørensen,Knut Hestad,

    INTRODUCTION: Few studies of cognitive impairment in COVID-19 convalescents have assessed patients longitudinally. The aim of this study was to examine the course of performance-based cognitive functions from 6 (T1) to 12 (T2) months after COVID-19 in patients compared with healthy controls, and to investigate the effect of psychiatric diagnosis and fatigue on cognitive function trajectories. METHODS: Eighty-one patients with confirmed SARS-CoV-2 infection reporting neurological symptoms were assessed at T1 and 67 patients at T2 with neuropsychological assessment and a semi-structured psychiatric interview. Fatigue was assessed using the Giessener Beschwerdebogen questionnaire (GBB). Sixty-one, confirmed SARS-CoV-2 antibody negative, healthy controls underwent neuropsychological assessment and completed GBB. RESULTS: At T1, patients performed significantly (p < 0.001 to 0.031) worse across the different cognitive domains, except for verbal fluency, than healthy controls. At T2, there were no significant differences between the two groups in either cognitive domain. Patients improved significantly from T1 to T2 on 7 of 8 domain scores (p < 0.001 to 0.033) and fatigue scores (p = 0.003). The frequency of psychiatric disorders decreased from 40% to 21%. Having a psychiatric diagnosis at T2 and/or delirium during acute COVID-19 significantly predicted a less favourable cognitive function course. CONCLUSION: These results suggest cognitive function, psychiatric morbidity and fatigue improve one year after COVID-19. Patients with ongoing psychiatric disorder and/or sequela following COVID-19-related delirium may constitute a vulnerable subgroup for non-improvement of cognitive function and should be specifically targeted for rehabilitation and treatment. TRIAL REGISTRATION: The study was registered the 09th of October 2020 at clinicaltrials.gov (NCT04576351).

    2026
    引用
    AI阅读
    加入学术空间
    3The Course of Insulin-Like Growth Factor Levels During Electroconvulsive Therapy
    Eva Kathrin Lamadé,Sebastian Karl, Anton Deicher,Suna Su Aksay, Gerrit Breitfelder,Moritz Spangemacher, Dorothea Kunz, Kent-Tjorben Böttcher, Shrabon Insan,Stephanie H. Witt,Michaela Coenen, Franziska Putschögl,

    Electroconvulsive therapy (ECT) is highly effective for treating severe psychiatric disorders. The molecular mechanisms underlying these disorders, and ECT’s effects remain incompletely understood. ECT may modulate growth factors and cytokines. Insulin-like growth factors (IGF)s link to neurogenesis and are altered in psychiatric disease. Data on longitudinal effects of ECT on the IGF-system across different psychiatric diagnoses, including IGF-1, IGF-binding protein 3 (IGFBP-3), IGF-2 and IGF-1/IGFBP-3 as proxy for free, active IGF-1 and its link to treatment response, is lacking. Patients undergoing ECT (n = 32) with mood disorders (n = 25) and psychotic disorders (n = 7) were investigated for IGF-1 and IGFBP-3, IGF-1/IGFBP-3 (quantified by CLIA) and IGF-2 (ELISA). Serum baseline IGF-levels were compared to levels after the sixth and last ECT and related to therapy response (global clinical improvement (CGI-I) ≤ 2 after last ECT). Associations of IGF-levels with CGI-I score were analyzed. IGF-1, IGF-1/IGFBP-3 but not IGF-2 were higher after the sixth ECT than baseline (p = 0.009; p = 0.031), adjusted for age, sex, BMI, main diagnosis and therapy response. IGF-levels did not differ between responders and non-responders. Lower global clinical improvement was linked with higher IGF-1 levels (p = 0.021), but not IGF-1/IGFBP-3 (p = 0.070), after adjusting for confounders. To our knowledge, this is the first study to longitudinally investigate the IGF-system across psychiatric diagnoses during ECT. IGF-1 and IGF-1/IGFBP-3 were elevated after the sixth ECT, independent of response. Higher symptom burden linked to higher IGF-1 and IGF-1/IGFBP-3. The observed changes may reflect neuroplastic processes, warranting mechanistic studies, but given the limited sample size, require confirmation in larger longitudinal studies.

    2026
    引用
    AI阅读
    加入学术空间
    4Volatilomics in Psychiatric Biomarker Research: from Odor Signatures to Multiomic Integration
    Baruh Polis, Thomas Frodl, Hossam Haick

    Schizophrenia remains a major challenge in psychiatry, with diagnosis still relying largely on symptom-based assessments and lacking validated biomarkers for early detection, screening, or longitudinal monitoring. Although genomic, transcriptomic, proteomic, and metabolomic studies have revealed systemic biological dysregulation involving immune, metabolic, and neurodevelopmental pathways, conventional multiomic approaches face significant translational limitations. They often require blood or tissue sampling and can be costly; although they include both dynamic, state-sensitive and more stable, trait-like signals, their complexity and sampling burden can limit frequent or population-level use. Volatilomics, the study of volatile organic compounds (VOCs) emitted through breath, sweat, and skin, has emerged as a complementary molecular approach that may help address these gaps. VOCs represent dynamic downstream metabolic outputs and may capture rapid, state-dependent biochemical changes. Analytical and machine-learning studies have reported VOC pattern alterations in schizophrenia with promising classification accuracy in small, early-stage discovery cohorts, although independent external validation remains limited. This review examines volatilomics as a promising complementary approach with potential applications in early detection and longitudinal monitoring, and considers how integration with systemic multiomics could contribute to diagnosis, patient stratification, and precision psychiatry.

    2026
    引用
    AI阅读
    加入学术空间
    5Feasibility and Interpretational Limits of Bright Light Therapy and Exercise for Depression Prevention in Youth with ADHD: Methodological and Conceptual Considerations
    Berkan Şahin, Merve Yildiz, Gülsüm Yitik Tonkaz
    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 9097 篇论文

    高被引作者

    作者引用发文
    R F Anda74962
    Vincent Felitti74962
    Shanta R. Dube69511
    John D. Walker69511
    Jules Angst540872
    Hans Asperger51821
    Hans-Jürgen Möller4648115
    Peter Falkai4045159
    Wulf Rossler307348
    Wolfgang Gaebel282460

    高产作者

    作者引用发文
    Peter Falkai4045159
    Hans-Jürgen Möller4648115
    Andrea Schmitt236691
    Jules Angst540872
    Wolfgang Gaebel282460
    Wolfgang Maier (Mediziner)275759
    Wulf Rossler307348
    Johann Steiner100645
    Alkomiet Hasan171445
    Kenji Hashimoto138943

    相关期刊

    Schizophrenia Research
    Bipolar Disorders
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry
    International journal of psychiatry in clinical practice
    Acta neuropsychiatrica
    Schizophrenia Bulletin
    European Neuropsychopharmacology
    Acta Psychiatrica Scandinavica
    International Journal of Bipolar Disorders
    European Archives of Psychiatry and Clinical Neuroscience